Value drivers of development stage biopharma companies.

Eur J Health Econ · 2022 · PMC9550717 · PMID 35038054

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Lead product characteristics The lead product’s development stage is the major highly significant value driver, explaining approximately 44.1% of firm valuation (Model 1).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.